Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 291,050 |
|
|||||
| News | - | ||||||
| Day High | 39.5795 | Low High |
|||||
| Day Low | 37.75 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Tarsus Pharmaceuticals Inc | TARS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.90 | -2.32% | 37.83 | 00:00:01 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 38.53 | 37.75 | 39.5795 | 37.83 | 38.73 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,580 | 291,050 | $ 38.46 | $ 11,194,214 | - | 12.57 - 42.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:49:37 | average | 2,366 | $ 37.83 | USD |
Tarsus Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.29B | 34.22M | - | 17.45M | -135.89M | -3.97 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Tarsus Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TARS Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 38.95 | 39.64 | 36.73 | 38.39 | 503,217 | -1.12 | -2.88% |
| 1 Month | 32.14 | 42.50 | 30.225 | 35.70 | 609,709 | 5.69 | 17.70% |
| 3 Months | 36.18 | 42.50 | 28.42 | 35.38 | 678,882 | 1.65 | 4.56% |
| 6 Months | 17.29 | 42.50 | 15.60 | 29.07 | 699,824 | 20.54 | 118.80% |
| 1 Year | 16.00 | 42.50 | 12.57 | 24.44 | 570,370 | 21.83 | 136.44% |
| 3 Years | 31.90 | 42.50 | 10.8001 | 22.55 | 250,476 | 5.93 | 18.59% |
| 5 Years | 18.30 | 63.69 | 10.8001 | 23.22 | 220,324 | 19.53 | 106.72% |
Tarsus Pharmaceuticals Description
| Tarsus Pharmaceuticals Inc is a late clinical-stage biopharmaceutical company. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's lead candidate TP-03, is a novel drug that targets the Demodex mite nervous system to kill the mites. |
